Dr Brenda D Gavin

KANDO id: 13555

Bio

Founding Partner of Quaker BioVentures. Previously: President of S.R. One, GlaxoSmithKline's venture capital arm, and general partner of EuclidSR Partners, an independent venture capital fund focused on healthcare and information technology. During her tenure with S.R. One, Dr Gavin was responsible for dozens of venture and strategic investments, and she served as a board member or active board observer for many portfolio companies. BioLeap, Celator Pharmaceuticals, Diasome Pharmaceuticals, Tengion, TetraLogic Pharmaceuticals, and Tranzyme Pharma. BS from Baylor University, Doctor of Veterinary Medicine magna cum laude from the University of Missouri, MBA from the University of Texas – San Antonio.

Education